Pfcrt haplotypes and in-vivo chloroquine response in Sundergarh district, Orissa, India

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 7, 2007, Pages 650-654

  Pati, Sudhanshu S ^a   Mishra, Sarojkanti ^a   Mohanty, Sanjib ^a   Mohapatra, Debendra N ^a   Sahu, Praveen K ^a   Priyadarshi, Neelam ^b   Kumar, S ^b   Sharma, Surya K ^c   Tyagi, Prajesh K ^c   Chitnis, Chetan E ^d   Das, Bhabani S ^a  

^a ISPAT GENERAL HOSPITAL   (India)

^b Kalta Iron Mines Hospital   (India)

^c NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^d INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

Chloroquine; Haplotype; India; Malaria; Pfcrt; Plasmodium falciparum

Indexed keywords

CARRIER PROTEIN; CHLOROQUINE; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER; PROTOZOAL DNA; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BLOOD SAMPLING; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; FREQUENCY ANALYSIS; HAPLOTYPE; HUMAN; IN VIVO STUDY; INDIA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MUTATIONAL ANALYSIS; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SOUTH AMERICA;

ANIMALS; ANTIMALARIALS; CHILD, PRESCHOOL; CHLOROQUINE; DRUG RESISTANCE; HAPLOTYPES; HUMANS; INDIA; INFANT; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; PROTOZOAN PROTEINS; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM;

EID: 34248179981     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.01.008     Document Type: Article

References (17)

1. Alifrangis M., Dalgaard M.B., Lusingu J.P., Vestergaard L.S., Staalsoe T., Jensen A.T., Enevold A., Ronn A.M., Khalil I.F., Warhurst D.C., Lemnge M.M., Theander T.G., and Bygbjerg I.C. Occurrence of Southeast Asian/South American SVMNT haplotype of the chloroquine-resistance transporter gene in Plasmodium falciparum in Tanzania. J. Infect. Dis. 193 (2006) 1738-1741
2. Ambrose O.T., Lugemwa J.K., Langi P., Mutabingwa T.K., Watkins W., Marck E.V., Egwang T., and Alessandro U.D. Role of the pfcrt codon 76 mutations as a molecular marker for population based surveillance of chloroquine resistant Plasmodium falciparum malaria in Ugandan sentinel sites with high chloroquine resistance. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 551-556
3. Chottopadhyay R., Sharma A., Srivastava V.K., Pati S.S., Sharma S.K., Das B.S., and Chitnis C.E. Plasmodium falciparum infection elicits both variant specific and cross-reactive antibodies against variant surface antigens. Infect. Immun. 71 (2003) 597-604
4. Cooper R.A., Hartwig C.L., and Ferdig M.T. pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta. Trop. 94 (2005) 170-180
5. Djimde A., Doumbo O.K., Cortese J.F., Kyentao K., Doumbo S., Diourte Y., Dicko A., Su X.-Z., Nomura T., Fidock D.A., Wellems T.E., and Plowe C.V. A molecular marker for chloroquine resistant falciparum malaria. N. Engl. J. Med. 344 (2001) 257-263
6. Djimde A., Doumbo O.K., Traore O., Guindo A.B., Kayentao K., Diourte Y., Niare-Doumbo S., Coulibaly D., Kone A.K., Cissoko Y., Tekete M., Fofana B., Dicko A., Diallo D.A., Wellems T.E., Kwiatkowski D., and Plowe C. Clearance of drug-resistant parasite as a model for protective immunity in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 69 (2003) 558-563
7. Dorsey G., Kamya M.R., Singh A., and Rosenthal P.J. Polymorphism in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J. Infect. Dis. 183 (2001) 1417-1420
8. Mittra P., Vinayak S., Chandawat H., Das M.K., Singh N., Biswas S., Dev V., Kumar A., Ansari M.A., and Sharma Y.D. Progressive increase in point mutations associated with chloroquine resistance in Plasmodium falciparum isolates from India. J. Infect. Dis. 193 (2006) 1304-1312
9. Mohanty S., Mishra S.K., Pati S.S., Pattnaik J.K., and Das B.S. Complications and mortality patterns due to Plasmodium falciparum malaria in hospitalized adults and children, Rourkela, Orissa, India. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 69-70
10. Pati S.S., Panigrahi J., Mishra S.K., Mohanty S., Mohapatra D.N., and Das B.S. Severe complications and death in cases of Plasmodium falciparum malaria with sickle-cell trait. Ann. Trop. Med. Parasitol. 99 (2005) 317-320
11. Sharma R.S., Sharma G.K., and Dhillon G.P.S. Epidemiology and Control of Malaria in India, Delhi (1996), National Malaria Eradication Program
12. Sharma S.K., Tyagi P.K., Pradhan K., Upadhyay A.K., Haque M.A., Nanda N., Joshi H., Biswas S., Adak T., Das B.S., Chauhan V.S., Chitnis C.E., and Subbarao S.K. Epidemiology of malaria transmission in forest and plain ecotype villages in Sundergarh District, Orissa, India. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 917-925
13. Vathsala P.G., Pramanik A., Dhanasekaran S., Usha Devi C., Pillai C.R., Subbarao S.K., Ghosh S.K., Tiwari S.N., Sathyanarayan T.S., Deshpande P.R., Mishra G.C., Ranjit M.R., Dash A.P., Rangarajan P.N., and Padmanaban G. Widespread occurrence of the Plasmodium falciparum chloroquine resistance transporter (Pfcrt) gene haplotype SVMTN in P. falciparum malaria in India. Am. J. Trop. Med. Hyg. 70 (2004) 256-259
14. Vinayak S., Biswas S., Dev V., Kumar A., Ansari M.A., and Sharma Y.D. Prevalence of K76T mutation in the pfcrt gene of Plasmodium falciparum among chloroquine responders in India. Acta. Trop. 87 (2003) 287-293
15. WHO, 1996. Assessment of Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with intense Transmission. Division of Control of Tropical Diseases, World Health Organization, Geneva, WHO/MAL/96.1077.
16. WHO. Severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 94 Suppl. 1 (2000)
17. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the treatment of Uncomplicated Falciparum Malaria. World Health Organization, Geneva, WHO/HTM/RBM/2003.50.